{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:06:57Z","timestamp":1791050817212,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.freeradbiomed.2007.05.032","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T15:36:50Z","timestamp":1181230610000},"page":"861-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Ahsan M.","family":"Kaimul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yodoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib1","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1016\/S0021-9258(18)97742-2","article-title":"Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B","volume":"239","author":"Laurent","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM197403072901019","article-title":"Letter: Two cases of T-cell chronic lymphocytic leukemia in Japan","volume":"290","author":"Yodoi","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4684-5323-2_14","article-title":"IL-2 receptor gene activation by ATL-derived factor (ADF)","volume":"213","author":"Yodoi","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/j.1460-2075.1989.tb03436.x","article-title":"ATL-derived factor (ADF), an IL-2 receptor\/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction","volume":"8","author":"Tagaya","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/ncb851","article-title":"Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69","volume":"4","author":"Haendeler","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib7","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.4049\/jimmunol.147.11.3837","article-title":"Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells","volume":"147","author":"Matsuda","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib8","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.freeradbiomed.2005.07.016","article-title":"Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt","volume":"39","author":"Kaimul Ahsan","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.febslet.2004.10.041","article-title":"Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression","volume":"577","author":"Haendeler","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib10","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI118668","article-title":"Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity","volume":"97","author":"Sasada","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/intimm\/7.6.985","article-title":"Suppression of adult T cell leukemia-derived factor\/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control","volume":"7","author":"Furuke","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib12","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1073\/pnas.87.21.8282","article-title":"Adult T-cell leukemia-derived factor\/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein\u2013Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2","volume":"87","author":"Wakasugi","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib13","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1016\/S0021-9258(18)71625-6","article-title":"Thioredoxin and glutaredoxin systems","volume":"264","author":"Holmgren","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib14","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1016\/S0021-9258(17)34519-2","article-title":"Glutathione-dependent enzyme reactions of the phage T4 ribonucleotide reductase system","volume":"253","author":"Holmgren","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib15","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1016\/S0021-9258(19)86818-7","article-title":"Reduction of disulfides by thioredoxin: exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action","volume":"254","author":"Holmgren","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib16","doi-asserted-by":"crossref","first-page":"10261","DOI":"10.1016\/S0021-9258(19)70458-X","article-title":"Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli","volume":"255","author":"Kallis","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0076-6879(84)07019-1","article-title":"Enzymatic reduction\u2013oxidation of protein disulfides by thioredoxin","volume":"107","author":"Holmgren","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib18","doi-asserted-by":"crossref","first-page":"29382","DOI":"10.1016\/S0021-9258(18)43889-6","article-title":"The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase","volume":"269","author":"Bjornstedt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib19","doi-asserted-by":"crossref","first-page":"33408","DOI":"10.1074\/jbc.M211107200","article-title":"Redox potential of human thioredoxin 1 and identification of a second dithiol\/disulfide motif","volume":"278","author":"Watson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib20","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/bi00088a023","article-title":"Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione","volume":"32","author":"Ren","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib21","doi-asserted-by":"crossref","first-page":"13979","DOI":"10.1021\/bi971004s","article-title":"Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 \u2192 asparagine mutant","volume":"36","author":"Andersen","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib22","doi-asserted-by":"crossref","first-page":"21645","DOI":"10.1074\/jbc.274.31.21645","article-title":"Identification of thioredoxin-binding protein-2\/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression","volume":"274","author":"Nishiyama","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0167-4781(94)90242-9","article-title":"Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3","volume":"1219","author":"Chen","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng811","article-title":"Positional cloning of the combined hyperlipidemia gene Hyplip1","volume":"30","author":"Bodnar","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/0008-5472.CAN-03-0908","article-title":"Loss of thioredoxin-binding protein-2\/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis","volume":"64","author":"Nishinaka","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib26","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/sj.onc.1209256","article-title":"Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2","volume":"25","author":"Ahsan","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib27","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1073\/pnas.182372299","article-title":"The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin","volume":"99","author":"Butler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fj.05-4439fje","article-title":"Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome","volume":"20","author":"Oka","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jn\/134.6.1475","article-title":"Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip\u2212\/\u2212 mice","volume":"134","author":"Donnelly","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1464-5491.2007.02109.x","article-title":"Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus","volume":"24","author":"van Greevenbroek","year":"2007","journal-title":"Diabetes Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib31","doi-asserted-by":"crossref","first-page":"15506","DOI":"10.1016\/S0021-9258(19)37617-3","article-title":"Cloning and expression of a cDNA for human thioredoxin","volume":"263","author":"Wollman","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/intimm\/7.4.625","article-title":"A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin","volume":"7","author":"Rosen","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.immunol.15.1.351","article-title":"Redox regulation of cellular activation","volume":"15","author":"Nakamura","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0065-230X(08)61004-0","article-title":"ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV","volume":"57","author":"Yodoi","year":"1991","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1008032703468","article-title":"Elevated serum level of thioredoxin in patients with hepatocellular carcinoma","volume":"11","author":"Miyazaki","year":"1998","journal-title":"Biotherapy"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib36","first-page":"3331","article-title":"Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas","volume":"22","author":"Choi","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib37","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/1097-0142(19920415)69:8<2091::AID-CNCR2820690814>3.0.CO;2-X","article-title":"Expression and growth-promoting effect of adult T-cell leukemia-derived factor: a human thioredoxin homologue in hepatocellular carcinoma","volume":"69","author":"Nakamura","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib38","first-page":"53","article-title":"Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer","volume":"24","author":"Nakamura","year":"2000","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib39","first-page":"2890","article-title":"Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray","volume":"62","author":"Han","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib40","first-page":"3087","article-title":"Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer","volume":"7","author":"Kakolyris","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/B:CBTO.0000004952.07979.3d","article-title":"Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues","volume":"19","author":"Kim","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0167-4781(94)90180-5","article-title":"The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors","volume":"1218","author":"Gasdaska","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15216540252774739","article-title":"Redox regulation by thioredoxin and thioredoxin-binding proteins","volume":"52","author":"Nishiyama","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/hp.2000.6546","article-title":"Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival","volume":"31","author":"Grogan","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib45","first-page":"3459","article-title":"Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia","volume":"16","author":"Berggren","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-2143(03)00068-4","article-title":"Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival","volume":"142","author":"Raffel","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0891-5849(00)00313-0","article-title":"The role of the redox protein thioredoxin in cell growth and cancer","volume":"29","author":"Powis","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib48","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","article-title":"Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1","volume":"17","author":"Saitoh","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2004.04.020","article-title":"Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN\u2019s lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN\u2019s tumor suppressor activity","volume":"429","author":"Meuillet","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib50","doi-asserted-by":"crossref","first-page":"20336","DOI":"10.1074\/jbc.M111899200","article-title":"Reversible inactivation of the tumor suppressor PTEN by H2O2","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib51","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1158\/1078-0432.CCR-05-0449","article-title":"High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer","volume":"11","author":"Kim","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib52","first-page":"4293","article-title":"Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide","volume":"55","author":"Yokomizo","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib53","first-page":"5089","article-title":"The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis","volume":"62","author":"Welsh","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib54","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-06-2250","article-title":"A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors","volume":"13","author":"Ramanathan","year":"2007","journal-title":"Clin, Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lab.2005.09.001","article-title":"The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma","volume":"147","author":"Baker","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/15230860260220201","article-title":"Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span","volume":"4","author":"Mitsui","year":"2002","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib57","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1073\/pnas.96.7.4131","article-title":"Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage","volume":"96","author":"Takagi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/biof.5520270105","article-title":"Thioredoxin-binding protein-2 (TBP-2): its potential roles in the aging process","volume":"27","author":"Yoshida","year":"2006","journal-title":"Biofactors"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tips.2005.06.005","article-title":"Thioredoxin: friend or foe in human disease?","volume":"26","author":"Burke-Gaffney","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/ars.2007.9.25","article-title":"Thioredoxin and related molecules\u2014From biology to health and disease","volume":"9","author":"Lillig","year":"2007","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib61","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.lfs.2006.03.026","article-title":"Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat","volume":"79","author":"Ueda","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semcancer.2006.09.001","article-title":"Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer","volume":"16","author":"Nakamura","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib63","doi-asserted-by":"crossref","first-page":"21884","DOI":"10.1074\/jbc.M600427200","article-title":"The interaction of thioredoxin with Txnip: evidence for formation of a mixed disulfide by disulfide exchange","volume":"281","author":"Patwari","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib64","first-page":"75","article-title":"Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620","volume":"9","author":"Takahashi","year":"2002","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/labinvest.3700280","article-title":"Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis","volume":"85","author":"Dutta","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib66","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.164.12.6287","article-title":"Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function","volume":"164","author":"Junn","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2004.01.047","article-title":"Heat shock factor regulates VDUP1 gene expression","volume":"315","author":"Kim","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib68","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1038\/sj.onc.1206610","article-title":"VDUP1 upregulated by TGF-beta1 and 1,25-dihydroxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression","volume":"22","author":"Han","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib69","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/sj.onc.1209394","article-title":"Hepatocellular carcinoma in Txnip-deficient mice","volume":"25","author":"Sheth","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2004.12.012","article-title":"VDUP1 is required for the development of natural killer cells","volume":"22","author":"Lee","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib71","first-page":"4045","article-title":"Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease","volume":"22","author":"Ikarashi","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.20670","article-title":"Downregulation of metastasis suppressor genes in malignant pheochromocytoma","volume":"114","author":"Ohta","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.LAB.0000053913.85892.E9","article-title":"Gene expression profile of serial samples of transformed B-cell lymphomas","volume":"83","author":"de Vos","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib74","first-page":"432","article-title":"Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP","volume":"63","author":"Goldberg","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncponc0106","article-title":"Drug insight: histone deacetylase inhibitors\u2014Development of the new targeted anticancer agent suberoylanilide hydroxamic acid","volume":"2","author":"Kelly","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib77","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2005.01.9679","article-title":"Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies","volume":"24","author":"O\u2019Connor","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib79","doi-asserted-by":"crossref","first-page":"37559","DOI":"10.1074\/jbc.M405473200","article-title":"Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2\/vitamin D(3)-up-regulated protein 1","volume":"279","author":"Nishinaka","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1464-5491.2007.02058.x","article-title":"Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia","volume":"24","author":"Miyazaki","year":"2007","journal-title":"Diabetes Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib81","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.188.8.1445","article-title":"Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes","volume":"188","author":"Hotta","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib82","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ndt\/gfm099","article-title":"Overexpression of thioredoxin 1 in transgenic mice suppresses development of diabetic nephropathy","volume":"22","author":"Hamada","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/152308604771978381","article-title":"Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats","volume":"6","author":"Tanito","year":"2004","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/intimm\/8.4.603","article-title":"Elevation of plasma thioredoxin levels in HIV-infected individuals","volume":"8","author":"Nakamura","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib85","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.44.1127","article-title":"Increased plasma levels of thioredoxin in patients with glucose intolerance","volume":"44","author":"Miyamoto","year":"2005","journal-title":"Intern. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib86","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/hq0901.095550","article-title":"Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis","volume":"21","author":"Okuda","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1253\/circj.69.291","article-title":"Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors","volume":"69","author":"Miwa","year":"2005","journal-title":"Circ. J."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib88","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2002-23201","article-title":"Elevation of serum thioredoxin levels in patients with type 2 diabetes","volume":"34","author":"Kakisaka","year":"2002","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib89","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/hep.510270601","article-title":"Hepatic steatosis: innocent bystander or guilty party?","volume":"27","author":"Day","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","article-title":"Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"38","author":"Sumida","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hepres.2004.02.002","article-title":"Control of oxidative stress and reduction in biochemical markers by vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study","volume":"29","author":"Kawanaka","year":"2004","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib92","doi-asserted-by":"crossref","first-page":"30369","DOI":"10.1074\/jbc.M400549200","article-title":"Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein","volume":"279","author":"Schulze","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib93","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbrc.2005.08.161","article-title":"Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein","volume":"336","author":"Minn","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib94","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2006.06.027","article-title":"Exenatide inhibits \u03b2-cell apoptosis by decreasing thioredoxin-interacting protein","volume":"346","author":"Chen","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2006.07.109","article-title":"Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes","volume":"1116","author":"Price","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib96","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1046\/j.1523-1755.2003.00263.x","article-title":"Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells","volume":"64","author":"Kobayashi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib97","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI200523001","article-title":"Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells","volume":"115","author":"Yamawaki","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib98","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00109-006-0109-6","article-title":"Thioredoxin in the cardiovascular system","volume":"84","author":"World","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","article-title":"Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)","volume":"36","author":"Pajukanta","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.a.30036","article-title":"Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia","volume":"130","author":"van der Vleuten","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1119(01)00455-3","article-title":"Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene","volume":"269","author":"Ludwig","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib102","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/bbrc.2000.3392","article-title":"Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes","volume":"275","author":"Hirota","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10715760100300561","article-title":"Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes","volume":"35","author":"Dekigai","year":"2001","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.freeradbiomed.2007.05.032_bib104","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4866-04.2005","article-title":"Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage","volume":"25","author":"Tanito","year":"2005","journal-title":"J. Neurosci."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584907003838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584907003838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T16:27:52Z","timestamp":1760200072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584907003838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0891584907003838"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.05.032","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}